Integra LifeSciences Holdings Cor.../ US4579852082 /
| 2024-05-03 7:43:52 PM | Chg. +0.5600 | Volume | Bid7:44:01 PM | Ask7:44:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 29.3100USD | +1.95% | 619,450 Turnover: 13.18 mill. |
29.3100Bid Size: 100 | 29.3300Ask Size: 100 | 2.29 bill.USD | - | 34.46 |
Assets
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 222.3690 | 269.2510 | 300.1120 | 337.4040 | 287.5290 | ||||||
| Intangible Assets | 561.1750 | 1,159.6270 | 1,079.4960 | 1,031.5910 | 989.4360 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 1,312.7840 | 2,389.1110 | 2,332.8050 | 2,445.0720 | 2,377.9340 | ||||||
| Inventories | 217.2630 | 296.3320 | 280.3470 | 316.0540 | 310.1170 | ||||||
| Accounts Receivable | 148.1860 | 251.7990 | 265.7370 | 275.2960 | 225.5320 | ||||||
| Cash and Cash Equivalents | 102.0550 | 174.9350 | 138.8380 | 198.9110 | 470.1660 | ||||||
| Current Assets | 495.1700 | 822.1460 | 775.0820 | 858.1680 | 1,237.2020 | ||||||
| Total Assets | 1,807.9540 | 3,211.2570 | 3,107.8870 | 3,303.2400 | 3,615.1360 | ||||||
Liabilities
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 29.0570 | 93.9670 | 76.0500 | 113.0900 | 54.6080 | ||||||
| Long-term debt | 665 | 1,781.1420 | 1,331.7130 | 1,303.0610 | 1,408.2210 | ||||||
| Liabilities to Banks | 665 | 1,841.1000 | 1,354.2000 | 1,348.1000 | - | ||||||
| Provisions | 148.9000 | 65.1000 | 57.8000 | 36.6000 | - | ||||||
| Liabilities | 968.2870 | 2,248.9510 | 1,732.0910 | 1,886.5040 | 2,100.2690 | ||||||
| Share Capital | .7770 | .8130 | .8800 | .8870 | .8930 | ||||||
| Total Equity | 839.6670 | 962.3060 | 1,375.7960 | 1,416.7360 | 1,514.8670 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 1,807.9540 | 3,211.2570 | 3,107.8870 | 3,303.2400 | 3,615.1360 | ||||||
Income Statement
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 992.0750 | 1,188.2360 | 1,472.4410 | 1,517.5570 | 1,371.8680 | ||||||
| Depreciation (total) | 72.6650 | 88.9450 | 110.7300 | 109.4620 | 116.0310 | ||||||
| Operating Result | 115.3400 | 44.8040 | 110.9980 | 93.7600 | 151.3700 | ||||||
| Interest Income | -25.7790 | -34.7640 | -61.8830 | -43.1780 | -62.2840 | ||||||
| Income Before Taxes | 90.4060 | 11.3850 | 57.4030 | 60.1040 | 93.5200 | ||||||
| Income Taxes | 15.8420 | -53.3580 | -3.3980 | 9.9030 | -40.3720 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 74.5640 | 64.7430 | 60.8010 | 50.2010 | 133.8920 | ||||||
Per Share
Cash Flow
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 116.4050 | 114.5440 | 199.6830 | 231.4330 | 203.8320 | ||||||
| Cash Flow from Investing Activities | -42.6220 | -1,221.3350 | -49.7050 | -162.6680 | -68.0730 | ||||||
| Cash Flow from Financing | -15.1160 | 1,168.9470 | -180.8720 | -8.7660 | 121.6250 | ||||||
| Decrease / Increase in Cash | 53.9230 | 72.8800 | -36.0970 | 60.0730 | 271.2550 | ||||||
| Employees | 3,700 | 4,400 | 4,500 | 4,000 | - | ||||||
